Rare diseases
Investigational molecules
Locations
480 Arsenal Way Suite 100, 02472-2895, United States
The sponsor concentrates on advancing treatment options for women with gynecologic malignancies, with particular emphasis on endometrial adenocarcinoma. Their research portfolio addresses the clinical needs of patients diagnosed with endometrial cancer, representing a significant area of unmet medical need in women's health.
The investigational approach explores innovative mechanisms to address endometrial malignancies, reflecting a commitment to expanding therapeutic possibilities for patients with these challenging cancers.
Acrivon Therapeutics Inc. runs clinical trials in conditions such as Endometrial cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
